Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Bourron, O"" wg kryterium: Autor


Wyświetlanie 1-9 z 9
Tytuł:
Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts.
Autorzy:
Denimal D; Center for Translational and Molecular Medicine, INSERM UMR 1231, Dijon, France.; Department of Clinical Biochemistry, Dijon Bourgogne University Hospital, Dijon, France.
Ponnaiah M; Institute of Cardiometabolism and Nutrition (ICAN), Paris, France.
Jeannin AC; Sorbonne Université, Paris, France.; Department of Diabetology, Assistance Publique‑Hôpitaux de Paris (APHP), Pitié-Salpêtrière Hospital, 47‑83 Boulevard de l'Hôpital, Paris, France.
Phan F; Sorbonne Université, Paris, France.; Centre de Recherche des Cordeliers, INSERM UMR_S 1138, Paris, France.; Department of Diabetology, Assistance Publique‑Hôpitaux de Paris (APHP), Pitié-Salpêtrière Hospital, 47‑83 Boulevard de l'Hôpital, Paris, France.
Hartemann A; Centre de Recherche des Cordeliers, INSERM UMR_S 1138, Paris, France.; Department of Diabetology, Assistance Publique‑Hôpitaux de Paris (APHP), Pitié-Salpêtrière Hospital, 47‑83 Boulevard de l'Hôpital, Paris, France.
Boussouar S; Institute of Cardiometabolism and Nutrition (ICAN), Paris, France.; Laboratoire d'Imagerie Biomédicale INSERM_1146, CNRS_7371, Paris, France.; ICT Cardiovascular and Thoracic Imaging Unit, Assistance Publique‑Hôpitaux de Paris (APHP), Pitié Salpêtrière University Hospital, Paris, France.
Charpentier E; Institute of Cardiometabolism and Nutrition (ICAN), Paris, France.; Laboratoire d'Imagerie Biomédicale INSERM_1146, CNRS_7371, Paris, France.; ICT Cardiovascular and Thoracic Imaging Unit, Assistance Publique‑Hôpitaux de Paris (APHP), Pitié Salpêtrière University Hospital, Paris, France.
Redheuil A; Institute of Cardiometabolism and Nutrition (ICAN), Paris, France.; Laboratoire d'Imagerie Biomédicale INSERM_1146, CNRS_7371, Paris, France.; ICT Cardiovascular and Thoracic Imaging Unit, Assistance Publique‑Hôpitaux de Paris (APHP), Pitié Salpêtrière University Hospital, Paris, France.
Foufelle F; Centre de Recherche des Cordeliers, INSERM UMR_S 1138, Paris, France.
Bourron O; Sorbonne Université, Paris, France. olivier.bourron@aphp.fr.; Centre de Recherche des Cordeliers, INSERM UMR_S 1138, Paris, France. olivier.bourron@aphp.fr.; Department of Diabetology, Assistance Publique‑Hôpitaux de Paris (APHP), Pitié-Salpêtrière Hospital, 47‑83 Boulevard de l'Hôpital, Paris, France. olivier.bourron@aphp.fr.
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Feb 13; Vol. 23 (1), pp. 69. Date of Electronic Publication: 2024 Feb 13.
Typ publikacji:
Clinical Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiovascular Diseases*/complications
Coronary Artery Disease*/diagnostic imaging
Coronary Artery Disease*/epidemiology
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/epidemiology
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/epidemiology
Vascular Calcification*/diagnostic imaging
Vascular Calcification*/epidemiology
Humans ; Biomarkers ; Calcium ; Cross-Sectional Studies ; Heart Disease Risk Factors ; Risk Factors
Czasopismo naukowe
Tytuł:
Cardiac adipose tissue volume assessed by computed tomography is a specific and independent predictor of early mortality and critical illness in COVID-19 in type 2-diabetic patients.
Autorzy:
Charpentier E; Sorbonne Université, Unité d'imagerie cardiovasculaire et thoracique, Hôpital La Pitié Salpêtrière (AP-HP), Laboratoire d'Imagerie Biomédicale, INSERM, CNRS, Institute of Cardiometabolism and Nutrition, Paris, France, Paris, France.
Redheuil A; Sorbonne Université, Unité d'imagerie cardiovasculaire et thoracique, Hôpital La Pitié Salpêtrière (AP-HP), Laboratoire d'Imagerie Biomédicale, INSERM, CNRS, Institute of Cardiometabolism and Nutrition, Paris, France, Paris, France. .
Bourron O; Sorbonne Université, Département de diabétologie, Hôpital La Pitié Salpêtrière (AP-HP), Institute of Cardiometabolism and Nutrition, Paris, France, Paris, France.; Centre de Recherche Des Cordeliers, INSERM, UMR_S 1138, Paris, France.
Boussouar S; Sorbonne Université, Unité d'imagerie cardiovasculaire et thoracique, Hôpital La Pitié Salpêtrière (AP-HP), Laboratoire d'Imagerie Biomédicale, INSERM, CNRS, Institute of Cardiometabolism and Nutrition, Paris, France, Paris, France.
Lucidarme O; Laboratoire d'Imagerie Biomédicale, INSERM, CNRS, Institute of Cardiometabolism and Nutrition, Sorbonne Université, Paris, France.; Service d'imagerie specialisee et d'urgence SISU, Hôpital Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris, Laboratoire d'Imagerie Biomédicale, INSERM, CNRS, Sorbonne Université, Paris, France.
Zarai M; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.
Kachenoura N; Laboratoire d'Imagerie Biomédicale, INSERM, CNRS, Institute of Cardiometabolism and Nutrition, Sorbonne Université, Paris, France.
Bouazizi K; Laboratoire d'Imagerie Biomédicale, INSERM, CNRS, Institute of Cardiometabolism and Nutrition, Sorbonne Université, Paris, France.
Salem JE; Department of Pharmacology, CIC-1901, INSERM, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris, France.
Hekimian G; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital La Pitié-Salpêtrière, Service de Médecine Intensive Réanimation, Sorbonne Université, Paris, France.
Kerneis M; AP-HP, Hôpital La Pitié-Salpêtrière, ACTION Study Group, Département de Cardiologie, Sorbonne Université, Paris, France.
Amoura Z; Service de Médecine Interne 2, Centre National de Référence Maladies Systémiques Rares et Histiocytoses, Institut e3M, Hôpital de La Pitié-Salpêtrière, AP-HP, Sorbonne Université, 75013, Paris, France.
Allenbach Y; AP-HP, Département de Médecine Interne Et Immunologie Clinique, Hôpital Pitié-Salpêtrière, Sorbonne Université, Paris, France.
Hatem S; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.
Jeannin AC; Sorbonne Université, Département de diabétologie, Hôpital La Pitié Salpêtrière (AP-HP), Institute of Cardiometabolism and Nutrition, Paris, France, Paris, France.
Andreelli F; Sorbonne Université, Département de diabétologie, Hôpital La Pitié Salpêtrière (AP-HP), Institute of Cardiometabolism and Nutrition, Paris, France, Paris, France.; Nutrition and ObesitiesSystemic Approaches (NutriOmics) Research Unit, INSERM, UMRS U1269, Sorbonne Université, Paris, France.
Phan F; Sorbonne Université, Département de diabétologie, Hôpital La Pitié Salpêtrière (AP-HP), Institute of Cardiometabolism and Nutrition, Paris, France, Paris, France.; Centre de Recherche Des Cordeliers, INSERM, UMR_S 1138, Paris, France.
Pokaż więcej
Corporate Authors:
COVID-19 APHP. SU Group
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2022 Dec 31; Vol. 21 (1), pp. 294. Date of Electronic Publication: 2022 Dec 31.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/complications
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/diagnosis
Humans ; Male ; Aged ; Female ; Critical Illness ; Retrospective Studies ; Adipose Tissue/diagnostic imaging ; Obesity/complications ; Obesity/diagnosis ; Obesity/epidemiology ; Tomography, X-Ray Computed/methods
Czasopismo naukowe
Tytuł:
Cardiac adipose tissue volume and IL-6 level at admission are complementary predictors of severity and short-term mortality in COVID-19 diabetic patients.
Autorzy:
Phan F; Sorbonne Université, Paris, France.; Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, La Pitié Salpêtrière-Charles Foix University Hospital, Paris, France.; Centre de Recherche des Cordeliers, INSERM, UMR_S 1138, Paris 06, France.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.
Boussouar S; Cardiovascular and Thoracic Imaging Unit, Hôpital Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris, France.; Laboratoire d'Imagerie Biomédicale, Sorbonne Université, INSERM, CNRS, Institute of Cardiometabolism and Nutrition, Paris, France.; Service d'imagerie Spécialisée et d'urgence SISU, Hôpital Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris, Laboratoire d'Imagerie Biomédicale, Sorbonne Université, INSERM, CNRS, Paris, France.
Lucidarme O; Laboratoire d'Imagerie Biomédicale, Sorbonne Université, INSERM, CNRS, Institute of Cardiometabolism and Nutrition, Paris, France.; Service d'imagerie Spécialisée et d'urgence SISU, Hôpital Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris, Laboratoire d'Imagerie Biomédicale, Sorbonne Université, INSERM, CNRS, Paris, France.
Zarai M; Laboratoire d'Imagerie Biomédicale, Sorbonne Université, INSERM, CNRS, Institute of Cardiometabolism and Nutrition, Paris, France.
Salem JE; Department of Pharmacology, CIC-1901, INSERM, Sorbonne Université, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Kachenoura N; Laboratoire d'Imagerie Biomédicale, Sorbonne Université, INSERM, CNRS, Institute of Cardiometabolism and Nutrition, Paris, France.
Bouazizi K; Laboratoire d'Imagerie Biomédicale, Sorbonne Université, INSERM, CNRS, Institute of Cardiometabolism and Nutrition, Paris, France.
Charpentier E; Cardiovascular and Thoracic Imaging Unit, Hôpital Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris, France.; Laboratoire d'Imagerie Biomédicale, Sorbonne Université, INSERM, CNRS, Institute of Cardiometabolism and Nutrition, Paris, France.; Service d'imagerie Spécialisée et d'urgence SISU, Hôpital Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris, Laboratoire d'Imagerie Biomédicale, Sorbonne Université, INSERM, CNRS, Paris, France.
Niati Y; Cardiovascular and Thoracic Imaging Unit, Hôpital Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris, France.
Bekkaoui H; Cardiovascular and Thoracic Imaging Unit, Hôpital Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris, France.
Amoura Z; Service de Médecine Interne 2, Centre National de Référence Maladies Systémiques Rares et Histiocytoses, Institut e3M, Hôpital de La Pitié-Salpêtrière, AP-HP, Sorbonne Université, 75013, Paris, France.
Mathian A; Service de Médecine Interne 2, Centre National de Référence Maladies Systémiques Rares et Histiocytoses, Institut e3M, Hôpital de La Pitié-Salpêtrière, AP-HP, Sorbonne Université, 75013, Paris, France.
Benveniste O; Département de Médecine Interne et Immunologie Clinique, Hôpital Pitié-Salpêtrière, Sorbonne Université, AP-HP, Paris, France.
Cacoub P; Département de Médecine Interne et Immunologie Clinique, Hôpital Pitié-Salpêtrière, Sorbonne Université, AP-HP, Paris, France.
Allenbach Y; Département de Médecine Interne et Immunologie Clinique, Hôpital Pitié-Salpêtrière, Sorbonne Université, AP-HP, Paris, France.
Saadoun D; Département de Médecine Interne et Immunologie Clinique, Hôpital Pitié-Salpêtrière, Sorbonne Université, AP-HP, Paris, France.
Lacorte JM; Department of Endocrine and Oncologic Biochemistry, Inserm, UMR_S 1166, Research Institute of Cardiovascular Disease, Metabolism and Nutrition, Paris, France.
Fourati S; Department of Endocrine and Oncologic Biochemistry, Inserm, UMR_S 1166, Research Institute of Cardiovascular Disease, Metabolism and Nutrition, Paris, France.
Laroche S; Sorbonne Université, Paris, France.; Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, La Pitié Salpêtrière-Charles Foix University Hospital, Paris, France.
Hartemann A; Sorbonne Université, Paris, France.; Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, La Pitié Salpêtrière-Charles Foix University Hospital, Paris, France.; Centre de Recherche des Cordeliers, INSERM, UMR_S 1138, Paris 06, France.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.
Bourron O; Sorbonne Université, Paris, France.; Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, La Pitié Salpêtrière-Charles Foix University Hospital, Paris, France.; Centre de Recherche des Cordeliers, INSERM, UMR_S 1138, Paris 06, France.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.
Andreelli F; Sorbonne Université, Paris, France.; Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, La Pitié Salpêtrière-Charles Foix University Hospital, Paris, France.; Nutrition and Obesities: Systemic Approaches (NutriOmics) Research Unit, Sorbonne Université, INSERM, UMRS U1269, Paris, France.
Redheuil A; Cardiovascular and Thoracic Imaging Unit, Hôpital Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris, France. .; Laboratoire d'Imagerie Biomédicale, Sorbonne Université, INSERM, CNRS, Institute of Cardiometabolism and Nutrition, Paris, France. .; Service d'imagerie Spécialisée et d'urgence SISU, Hôpital Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris, Laboratoire d'Imagerie Biomédicale, Sorbonne Université, INSERM, CNRS, Paris, France. .
Pokaż więcej
Corporate Authors:
COVID-19 APHP.SU Group
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2021 Aug 12; Vol. 20 (1), pp. 165. Date of Electronic Publication: 2021 Aug 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adipose Tissue/*pathology
COVID-19/*blood
Diabetes Mellitus, Type 2/*complications
Interleukin-6/*blood
Myocardium/*pathology
Adipose Tissue/diagnostic imaging ; Aged ; COVID-19/complications ; COVID-19/diagnostic imaging ; COVID-19/mortality ; Female ; Heart/diagnostic imaging ; Hospital Mortality ; Humans ; Intensive Care Units ; Male ; Middle Aged ; Organ Size ; Prognosis ; SARS-CoV-2 ; Severity of Illness Index ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł:
Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study.
Autorzy:
Bourron O; Sorbonne Université, Paris, France. olivier.bourron@aphp.fr.; Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, La Pitié Salpêtrière-Charles Foix University Hospital, Paris, France. olivier.bourron@aphp.fr.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France. olivier.bourron@aphp.fr.; INSERM, UMR_S 1138, Centre de Recherche des Cordeliers, Paris 06, France. olivier.bourron@aphp.fr.; Diabetology Department, Pitié-Salpêtrière Hospital, 47-83 Boulevard de l'Hôpital, Paris, France. olivier.bourron@aphp.fr.
Phan F; Sorbonne Université, Paris, France.; Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, La Pitié Salpêtrière-Charles Foix University Hospital, Paris, France.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.; INSERM, UMR_S 1138, Centre de Recherche des Cordeliers, Paris 06, France.
Diallo MH; Unité de Recherche Clinique Salpêtrière - Charles Foix, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, 75013, Paris, France.
Hajage D; Département de Santé, Centre de Pharmacoépidémiologie (Cephepi), CIC-1421, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, 75013, Paris, France.
Aubert CE; Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, La Pitié Salpêtrière-Charles Foix University Hospital, Paris, France.
Carlier A; Sorbonne Université, Paris, France.; Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, La Pitié Salpêtrière-Charles Foix University Hospital, Paris, France.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.
Salem JE; Sorbonne Université, Paris, France.; Department of Pharmacology and CIC-1421, AP-HP La Pitié Salpêtrière Charles Foix University Hospital, Paris, France.; INSERM, CIC-1901, Paris, France.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.
Funck-Brentano C; Sorbonne Université, Paris, France.; Department of Pharmacology and CIC-1421, AP-HP La Pitié Salpêtrière Charles Foix University Hospital, Paris, France.; INSERM, CIC-1901, Paris, France.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.
Kemel S; Sorbonne Université, Paris, France.; Laboratoire d'Imagerie Biomédicale INSERM_1146, CNRS_7371, Paris, France.; Assistance Publique-Hôpitaux de Paris (APHP), Department of Radiology, La Pitié Salpêtrière-Charles Foix University Hospital, Paris, France.
Cluzel P; Sorbonne Université, Paris, France.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.; Laboratoire d'Imagerie Biomédicale INSERM_1146, CNRS_7371, Paris, France.; Assistance Publique-Hôpitaux de Paris (APHP), Department of Radiology, La Pitié Salpêtrière-Charles Foix University Hospital, Paris, France.
Redheuil A; Sorbonne Université, Paris, France.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.; Laboratoire d'Imagerie Biomédicale INSERM_1146, CNRS_7371, Paris, France.; Assistance Publique-Hôpitaux de Paris (APHP), Department of Radiology, La Pitié Salpêtrière-Charles Foix University Hospital, Paris, France.
Davaine JM; Sorbonne Université, Paris, France.
Massy Z; Division of Nephrology, Ambroise Paré Hospital, AP-HP, Université Paris-Saclay, Paris, France.
Mentaverri R; INSERM_1088, Centre Universitaire de Recherche en Santé, Université de Picardie Jules Verne, Amiens, France.
Bonnefont-Rousselot D; Department of Metabolic Biochemistry, La Pitié Salpêtrière-Charles Foix University Hospital (AP-HP), Paris, France.; UTCBS, CNRS UMR8258 - INSERM_1267, Faculty of Pharmacy of Paris, University of Paris, Paris, France.
Gillery P; University of Reims- Champagne-Ardenne, CNRS, MEDyC UMR 7369, Reims, France.; Laboratory of Biochemisry-Pharmacology-Toxicology, University Hospital of Reims, Maison Blanche Hospital, Reims, France.
Jaisson S; University of Reims- Champagne-Ardenne, CNRS, MEDyC UMR 7369, Reims, France.; Laboratory of Biochemisry-Pharmacology-Toxicology, University Hospital of Reims, Maison Blanche Hospital, Reims, France.
Vermeer C; Cardiovascular Research Institute CARIM, Maastricht University, Maastricht, The Netherlands.
Lacorte JM; Sorbonne Université, Paris, France.; Department of Endocrine and Oncologic Biochemistry, AP-HP, Pitié-Salpêtrière Hospital, Paris, France.; INSERM U1166, Paris, France.
Bouziri N; Sorbonne University, ACTION Study Group, INSERM, UMRS 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, France.
Laroche S; Sorbonne Université, Paris, France.; Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, La Pitié Salpêtrière-Charles Foix University Hospital, Paris, France.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.
Amouyal C; Sorbonne Université, Paris, France.; Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, La Pitié Salpêtrière-Charles Foix University Hospital, Paris, France.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.
Hartemann A; Sorbonne Université, Paris, France.; Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, La Pitié Salpêtrière-Charles Foix University Hospital, Paris, France.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.; INSERM, UMR_S 1138, Centre de Recherche des Cordeliers, Paris 06, France.
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2020 Sep 18; Vol. 19 (1), pp. 140. Date of Electronic Publication: 2020 Sep 18.
Typ publikacji:
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 2/*blood
Diabetic Angiopathies/*blood
Lower Extremity/*blood supply
RANK Ligand/*blood
Triglycerides/*blood
Vascular Calcification/*blood
Aged ; Cohort Studies ; Diabetic Angiopathies/diagnostic imaging ; Diabetic Angiopathies/epidemiology ; Disease Progression ; Female ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Male ; Middle Aged ; Myocardial Ischemia/epidemiology ; Prospective Studies ; Tomography, X-Ray Computed ; Vascular Calcification/diagnostic imaging ; Vascular Calcification/epidemiology
Czasopismo naukowe
Tytuł:
Sphingosine-1-Phosphate Metabolism in the Regulation of Obesity/Type 2 Diabetes.
Autorzy:
Guitton J; Institut des Neurosciences Paris-Saclay, Université Paris Saclay, CNRS UMR 9197, F-91190 Orsay, France.
Bandet CL; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, F-75006 Paris, France.; Institut Hospitalo-Universitaire ICAN, F-75013 Paris, France.
Mariko ML; Institut des Neurosciences Paris-Saclay, Université Paris Saclay, CNRS UMR 9197, F-91190 Orsay, France.
Tan-Chen S; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, F-75006 Paris, France.; Institut Hospitalo-Universitaire ICAN, F-75013 Paris, France.
Bourron O; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, F-75006 Paris, France.; Institut Hospitalo-Universitaire ICAN, F-75013 Paris, France.; Assistance Publique-Hôpitaux de Paris, Département de Diabétologie et Maladies Métaboliques, Hôpital Pitié-Salpêtrière, F-75013 Paris, France.
Benomar Y; Institut des Neurosciences Paris-Saclay, Université Paris Saclay, CNRS UMR 9197, F-91190 Orsay, France.
Hajduch E; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, F-75006 Paris, France.; Institut Hospitalo-Universitaire ICAN, F-75013 Paris, France.
Le Stunff H; Institut des Neurosciences Paris-Saclay, Université Paris Saclay, CNRS UMR 9197, F-91190 Orsay, France.
Pokaż więcej
Źródło:
Cells [Cells] 2020 Jul 13; Vol. 9 (7). Date of Electronic Publication: 2020 Jul 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Diabetes Mellitus, Type 2/*metabolism
Lysophospholipids/*metabolism
Obesity/*metabolism
Sphingosine/*analogs & derivatives
Animals ; Energy Metabolism ; Humans ; Insulin/metabolism ; Mammals/metabolism ; Sphingosine/metabolism
Czasopismo naukowe
Tytuł:
Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes.
Autorzy:
Jeannin AC; Sorbonne Université, Paris, France.; Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, Pitié-Salpêtrière Hospital, Paris, France.
Salem JE; Sorbonne Université, Paris, France.; Department of Pharmacology and CIC-1421, AP-HP, Pitié-Salpêtrière Hospital, Paris, France.; INSERM, CIC-1421, Paris, France.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.
Massy Z; Division of Nephrology, Ambroise Paré Hospital, AP-HP, Pitié-Salpêtrière Hospital, Université Paris-Saclay, Paris, France.
Aubert CE; Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Vermeer C; Cardiovascular Research Institute CARIM, Maastricht University, Maastricht, The Netherlands.
Amouyal C; Sorbonne Université, Paris, France.; Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, Pitié-Salpêtrière Hospital, Paris, France.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.
Phan F; Sorbonne Université, Paris, France.; Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, Pitié-Salpêtrière Hospital, Paris, France.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.; INSERM, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France.
Halbron M; Sorbonne Université, Paris, France.; Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, Pitié-Salpêtrière Hospital, Paris, France.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.
Funck-Brentano C; Sorbonne Université, Paris, France.; Department of Pharmacology and CIC-1421, AP-HP, Pitié-Salpêtrière Hospital, Paris, France.; INSERM, CIC-1421, Paris, France.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.
Hartemann A; Sorbonne Université, Paris, France.; Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, Pitié-Salpêtrière Hospital, Paris, France.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.; INSERM, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France.
Bourron O; Sorbonne Université, Paris, France.; Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, Pitié-Salpêtrière Hospital, Paris, France.; Institute of Cardiometabolism and Nutrition ICAN, Paris, France.; INSERM, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Feb 24; Vol. 15 (2), pp. e0229145. Date of Electronic Publication: 2020 Feb 24 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Calcium-Binding Proteins/*blood
Diabetes Mellitus, Type 2/*complications
Extracellular Matrix Proteins/*blood
Peripheral Nervous System Diseases/*etiology
Aged ; Biomarkers/blood ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Peripheral Nervous System Diseases/blood ; Risk Factors ; Vitamin K/blood ; Matrix Gla Protein
Czasopismo naukowe
Tytuł:
Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients.
Autorzy:
Mary A; INSERM U-1088, Pathophysiological Mechanisms and Consequences of Cardiovascular Calcifications, 80025, Amiens, France. .; Amiens University Medical Center, Pharmacy, 80054, Amiens, France. .; Universite de Picardie Jules Verne, UFR Pharmacie, 80025, Amiens, France. .
Hartemann A; Pitié Salpêtrière Hospital, Diabetology, 75005, Paris, France.; Universite Paris-Sorbonne, UMPC - Paris 06, 75005, Paris, Île-de-France, France.; INSERM UMR_S 1138, Centre de recherche des Cordeliers, 75006, Paris, France.; Institute of Cardiometabolism and Nutrition, Paris, France.
Liabeuf S; INSERM U-1088, Pathophysiological Mechanisms and Consequences of Cardiovascular Calcifications, 80025, Amiens, France.; Universite de Picardie Jules Verne, UFR Pharmacie, 80025, Amiens, France.; Amiens University Hospital, Clinical Research Centre, Division of Clinical Pharmacology, 80054, Amiens, France.
Aubert CE; INSERM UMR_S 1138, Centre de recherche des Cordeliers, 75006, Paris, France.; Bern University Hospital, University of Bern, General Internal Medicine, 3012, Bern, Switzerland.
Kemel S; Universite Paris-Sorbonne, UMPC - Paris 06, 75005, Paris, Île-de-France, France.; Pitié Salpêtrière Hospital, Cardiovascular and Interventional Radiology, 75005, Paris, France.; FRANCE2Biomedical Imaging Lab, 75006, Paris, France.
Salem JE; Universite Paris-Sorbonne, UMPC - Paris 06, 75005, Paris, Île-de-France, France.; Institute of Cardiometabolism and Nutrition, Paris, France.; Pitié Salpêtrière Hospital, Pharmacology, 75005, Paris, France.; Pitié Salpêtrière Hospital, Clinical Investigation Center, CIC-1421, 75005, Paris, France.
Cluzel P; Universite Paris-Sorbonne, UMPC - Paris 06, 75005, Paris, Île-de-France, France.; Pitié Salpêtrière Hospital, Cardiovascular and Interventional Radiology, 75005, Paris, France.; FRANCE2Biomedical Imaging Lab, 75006, Paris, France.
Lenglet A; INSERM U-1088, Pathophysiological Mechanisms and Consequences of Cardiovascular Calcifications, 80025, Amiens, France.; Amiens University Medical Center, Pharmacy, 80054, Amiens, France.; Universite de Picardie Jules Verne, UFR Pharmacie, 80025, Amiens, France.
Massy ZA; Ambroise Paré Hospital, Nephrology, 92104, Boulogne-Billancourt, France.; Universite Versailles Saint-Quentin-en-Yvelines, Paris-Ile-de-France-Ouest, 78000, Versailles, France.; INSERM U-1018, Research Centre in Epidemiology and Population Health (CESP) Team 5, 94807, Villejuif, France.
Lalau JD; INSERM U-1088, Pathophysiological Mechanisms and Consequences of Cardiovascular Calcifications, 80025, Amiens, France.; Amiens University Medical Center, Endocrinology and Nutrition, 80054, Amiens, France.; Universite de Picardie Jules Verne, UFR Médecine, 80025, Amiens, France.
Mentaverri R; INSERM U-1088, Pathophysiological Mechanisms and Consequences of Cardiovascular Calcifications, 80025, Amiens, France.; Universite de Picardie Jules Verne, UFR Pharmacie, 80025, Amiens, France.; Amiens University Hospital, Bone and Endocrine Biology, 80054, Amiens, France.
Bourron O; Pitié Salpêtrière Hospital, Diabetology, 75005, Paris, France.; Universite Paris-Sorbonne, UMPC - Paris 06, 75005, Paris, Île-de-France, France.; INSERM UMR_S 1138, Centre de recherche des Cordeliers, 75006, Paris, France.; Institute of Cardiometabolism and Nutrition, Paris, France.
Kamel S; INSERM U-1088, Pathophysiological Mechanisms and Consequences of Cardiovascular Calcifications, 80025, Amiens, France. .; Universite de Picardie Jules Verne, UFR Pharmacie, 80025, Amiens, France. .; Amiens University Hospital, Biochemistry, 80054, Amiens, France. .
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2017 Feb 15; Vol. 16 (1), pp. 24. Date of Electronic Publication: 2017 Feb 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 2/*drug therapy
Diabetic Angiopathies/*prevention & control
Hypoglycemic Agents/*therapeutic use
Leg/*blood supply
Metformin/*therapeutic use
Peripheral Arterial Disease/*prevention & control
Vascular Calcification/*prevention & control
Aged ; Chi-Square Distribution ; Computed Tomography Angiography ; Cross-Sectional Studies ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/diagnosis ; Diabetic Angiopathies/diagnostic imaging ; Diabetic Angiopathies/etiology ; Female ; Humans ; Hypoglycemic Agents/adverse effects ; Logistic Models ; Male ; Metformin/adverse effects ; Middle Aged ; Multivariate Analysis ; Odds Ratio ; Peripheral Arterial Disease/diagnostic imaging ; Peripheral Arterial Disease/etiology ; Protective Factors ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome ; Ultrasonography, Doppler, Color ; Vascular Calcification/diagnostic imaging ; Vascular Calcification/etiology
Czasopismo naukowe
Tytuł:
Erratum: Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein.
Autorzy:
Liabeuf S; INSERM U1088, Jules Verne University of Picardy, Amiens, F-80000, France. .
Bourron O
Vemeer C
Theuwissen E
Magdeleyns E
Aubert CE
Brazier M
Mentaverri R
Hartemann A
Massy ZA
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2015 Jan 24; Vol. 14, pp. 9. Date of Electronic Publication: 2015 Jan 24.
Typ publikacji:
Journal Article; Comment; Published Erratum
MeSH Terms:
Calcium-Binding Proteins/*blood
Diabetes Mellitus, Type 2/*blood
Diabetes Mellitus, Type 2/*diagnosis
Extracellular Matrix Proteins/*blood
Vascular Calcification/*blood
Vascular Calcification/*diagnosis
Female ; Humans ; Male
Czasopismo naukowe
Tytuł:
Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein.
Autorzy:
Liabeuf S
Bourron O
Olivier B
Vemeer C
Theuwissen E
Magdeleyns E
Aubert CE
Brazier M
Mentaverri R
Hartemann A
Massy ZA; INSERM U1088, Jules Verne University of Picardy, F-80000 Amiens, France. .
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2014 Apr 24; Vol. 13, pp. 85. Date of Electronic Publication: 2014 Apr 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Calcium-Binding Proteins/*blood
Diabetes Mellitus, Type 2/*blood
Diabetes Mellitus, Type 2/*diagnosis
Extracellular Matrix Proteins/*blood
Vascular Calcification/*blood
Vascular Calcification/*diagnosis
Aged ; Biomarkers/blood ; Cohort Studies ; Cross-Sectional Studies ; Diabetes Mellitus, Type 2/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Vascular Calcification/epidemiology ; Matrix Gla Protein
Czasopismo naukowe
    Wyświetlanie 1-9 z 9

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies